1 - 15 of 46 Results Clear All
Gladstone researchers are collaborating to solve cardiovascular diseases using new technologies.
Gladstone Experts Research Heart Failure Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Virology and Immunology Bruneau Lab Conklin Lab Krogan Lab
Why should athletes and sports fans have all the fun in March?
Gladstone Experts Institutional News Huang Lab Srivastava Lab
STAT—Two Gladstone studies have been selected to participate in STAT Madness—a March Madness-style competition for scientific papers. Voting begins March 2, 2020.
Gladstone Experts Huang Lab Srivastava Lab
Aging is the single greatest risk factor for developing Alzheimer’s disease, Parkinson’s disease, and other brain diseases.
Gladstone Experts Cardiovascular Disease Neurological Disease Finkbeiner Lab McDevitt Lab Srivastava Lab Aging
From penicillin to organ transplants, so many important discoveries have dramatically changed healthcare and medicine over the past decades. But what’s really behind all this progress?
Gladstone Experts Research Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab Yamanaka Lab
France 24—On France 24, Gladstone President Deepak Srivastava explains CRISPR technology and the potential is has to cure disease.
Gladstone Experts Srivastava Lab
Funds will support five top research institutions to accelerate scientific discoveries and development of treatments for single ventricle heart defects.
Grants News Release Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab Srivastava Lab
Bloomberg Law—Gladstone President Deepak Srivastava comments in Bloomberg Law on the Trump Administration’s plan to implement a fetal tissue ethics review board. Srivastava states that a once-a-year review board will hold up important medical research.
Gladstone Experts Srivastava Lab
Gladstone started as a single institute in 1979 but has since grown to four institutes which use cutting-edge technology to tackle cardiovascular, neurological, and immunological diseases.
History Cardiovascular Disease Data Science and Biotechnology Neurological Disease Virology and Immunology Greene Lab Mahley Lab Mucke Lab Pollard Lab Srivastava Lab
Team of six laboratories will combine expertise in heart development and -omics technology to probe genome activity and organization in heart cells.
Grants News Release Heart Failure Bruneau Lab Conklin Lab Krogan Lab Pollard Lab Srivastava Lab
Gladstone began as a single entity with a single purpose. But as the scientists followed the science—unencumbered by the red tape of bureaucracy—the purpose, and the focus, grew.
History Institutional News Cardiovascular Disease Data Science and Biotechnology Neurological Disease Virology and Immunology Finkbeiner Lab Greene Lab Mahley Lab Mucke Lab
Gladstone prepares for the future of discovery science with the launch of new strategic plan.
Office of the President History Institutional News Srivastava Lab
The Washington Post—Gladstone President Deepak Srivastava comments in the Washington Post on a new study that debunks controversial stem cell procedures.
Gladstone Experts Srivastava Lab
Since Shinya Yamanaka discovered a method to create human induced pluripotent stem cells (hiPS cells), Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.
Research Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing Stem Cells/iPSCs
Gladstone scientists gain important insights into the cellular reprogramming process
News Release Research Heart Failure Cardiovascular Disease Pollard Lab Srivastava Lab Big Data Stem Cells/iPSCs